VANCOUVER, May 25, 2011 /CNW/ - Studies looking at anticancer drugs from
the ocean to preventative health care among adult cancer survivors are
among four research projects being funded by the Canadian Cancer
Society BC and Yukon today.
"With these new projects, the Canadian Cancer Society continues to
support a vibrant research community that is seeking ways to reduce
cancer risk, reduce cancer deaths and improve the quality of life of
those living with cancer," says Barbara Kaminsky, CEO, Canadian Cancer
Society BC and Yukon. "We are very grateful to our generous British
Columbia and Yukon donors for making the research possible."
The four grants worth $1.668 million are part of 52 new research
projects worth more than $21 million announced by the Society. The
projects cover a broad spectrum of cancer research from risk reduction
to genetic studies to drug development and palliative care.
Research is one of the three pillars the Canadian Cancer Society focuses
on. The Society also provides support services to those on a cancer
journey and their families and leads the way in cancer prevention.
The 2011 research grant recipients include:
Dr. Raymond Andersen, UBC ($420,527)
Many common drugs have come from nature and Dr Andersen's study looks to
the world's oceans as a resource for new, naturally occurring
antiâ€'cancer substances. The goal of this project is to discover new
organic compounds that are present in marine invertebrates and
microorganisms to develop new drug treatments for cancer, with a
particular focus on advanced stage prostate cancer.
"The ocean is a rich and diverse source of inspiration for cancer
treatment," says Dr Andersen, an organic chemist at the University of
British Columbia. "Our goal is to harness their power to create better
and safer drug treatments for cancer patients. This is a young field of
research with a lot of promise."
Dr. Lawrence McIntosh, UBC ($392,839)
Using a powerful technique called magnetic resonance spectroscopy, Dr
McIntosh is studying the structure of several proteins - ETS factors -
that are part of the molecular machines that read the genes encoded
within DNA. The project will examine how ETS factors work in normal
cells and why cancers result when they are modified with the ultimate
goal of developing new diagnostic tests and drug targets.
Dr. Winson Cheung, BC Cancer Agency ($423, 000)
With improvements in cancer survival rates there are a growing number of
cancer survivors, many of whom will become longâ€'term survivors facing
new risks related to their health such as heart disease, diabetes or
osteoporosis. Using large databases in B.C. that contain information
about cancer, medical procedures, doctors visits and medication use, Dr
Cheung is leading the first large-scale study of its kind to
investigate whether adult cancer survivors are receiving appropriate
preventive care. The results of this work will inform the development
of future health policies and programs.
Dr. Gang Li, UBC ($423, 000)
The role of ING tumour suppressors in nucleotide excision repair
Dr Li's research team is investigating the molecular mechanisms that
help to repair DNA after it has been damaged by ultraviolet light (UV),
a key risk factor for skin cancer. Their study will look at how
growth-inhibiting proteins work together to repair DNA, influence the
body's ability to recognize UV-damaged DNA and how they facilitate the
ability of repair proteins to do their job.
The Canadian Cancer Society is a national community-based organization
of volunteers whose mission is the eradication of cancer and the
enhancement of the quality of life of people living with cancer. When
you want to know more about cancer, visit our website www.cancer.ca or call our toll-free, bilingual Cancer Information Service at 1 888
SOURCE Canadian Cancer Society (BC and Yukon Division)
For further information:
Manager, Media Relations
Canadian Cancer Society, BC and Yukon Division
Direct line: 604.675.7340 Cell: 604.837.5643